Inventia Healthcare Limited Fenofibrate Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Fenofibrate Export Records India — #12 Exporter, 60 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fenofibrate

India Pharmaceutical Trade Intelligence

$73.4M168 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES43.4%India → BELGIUM8.7%

ImportsUNITED STATES → India$13.3K CANADA → India$3.1K

#1 Buyer: YUSEN LOGISTICS

Inventia Healthcare Limited — Fenofibrate Exporter #12 | $1.4M Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Fenofibrate Exporter Profile

Indian Pharmaceutical Exporter · #12 for Fenofibrate · $1.4M export value · DGFT Verified

Inventia Healthcare Limited is the #12 Indian exporter of Fenofibrate with $1.4M in export value and 60 verified shipments. Inventia Healthcare Limited holds a 2.0% market share in Fenofibrate exports across 4 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Fenofibrate Export Profile: Buyers & Destinations

Inventia Healthcare Limited Fenofibrate export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Fenofibrate?

Country	Value	Shipments	Share
UNITED STATES	$838.9K	23	67.7%
MYANMAR	$332.7K	28	26.9%
VIETNAM, DEMOCRATIC REP. OF	$41.4K	6	3.3%
VIETNAM DEMOCRATIC REP. OF	$15.0K	1	1.2%
VIETNAM	$7.8K

Who Are the Top Buyers of Fenofibrate from Inventia Healthcare Limited?

Buyer	Country	Value	Orders
ANIP ACQUISITION COMPANY	UNITED STATES	$711.8K	20
MYIT MAHAR TRADING CO LTD	MYANMAR	$139.7K	9
EVERSANA	UNITED STATES	$127.1K	3
MYIT MAHAR TRADING CO., LTD	MYANMAR	$51.1K	3
LWIN AND MYINT TRADING COMPANY LIM	MYANMAR	$45.5K	2
LWIN AND MYINT TRADING COMPANY LIMI	MYANMAR	$38.5K	7
MAXXCARE COMPANY LIMITED.	VIETNAM, DEMOCRATIC REP. OF	$31.0K	3
MYIT MAHAR TRADING CO LIMITED	MYANMAR	$27.8K	2
LWIN AND MYINT TRADING CO LTD	MYANMAR	$15.0K	2
LWIN AND MYINT TRADING COMPANY	MYANMAR	$15.0K	3

Inventia Healthcare Limited supplies Fenofibrate to 14 buyers globally. The largest buyer is ANIP ACQUISITION COMPANY (UNITED STATES), followed by MYIT MAHAR TRADING CO LTD (MYANMAR) and EVERSANA (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fenofibrate Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
PHARMACEUTICAL MATERIALS- FENOFIBRATE CA	$200.0K	4
PHARMACEUTICAL MATERIALS FENOFIBRATE CAP	$127.1K	3
PHARMACEUTICAL MATERIALS FENOFIBRATE CAPSULES USP 134 MG 100S NDC NO. 439753051	$95.4K	2
BRANDTONACT FN ATORVASTATIN 10 MG ANDFENOFIBRATE 160 MG TABLETS PACK 10 X 10 NOS CARTON	$50.0K	2
PHARMACEUTICAL MATERIALS - FENOFIBRATE CAPSULES USP 134 MG 100'S 1X100 NDC NO. 4397530510	$50.0K	1
BRANDTONACT FN (ATORVASTATIN 10 MG ANDFENOFIBRATE 160 MG TABLETS) (PACK SIZE10X10)(NOS=CARTONS)NOS	$50.0K	1
FENOFIBRATE CAPSULES USP 200 MG 100' NDC NO. 4397530610 (1X100 )	$50.0K	1
PHARMACEUTICAL MATERIALS - FENOFIBRATE CAPSULES USP 134 MG 100'S NDC NO. 43975-305-10	$50.0K	1
COLESTRIM (EACH FILM COATED TABLETCONTAIN FENOFIBRATE B.P.160MG)	$45.5K	2
BRAND:TONACT FN (ATORVASTATIN 10 MG AND FENOFIBRATE 160 MG TABLETS)(PACK SIZE:10X10)(NOS=CARTON)	$45.0K	1

Inventia Healthcare Limited exports 39 distinct Fenofibrate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL MATERIALS- FENOFIBRATE CA with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Inventia Healthcare Limited Compare to Nearest Fenofibrate Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ABBOTT HEALTHCARE PRIVATE LIMITED	$2.5M	50	5	$50.0K
11	ALEMBIC PHARMACEUTICALS LIMITED	$1.5M	129	1	$11.6K
12	INVENTIA HEALTHCARE LIMITED ★	$1.4M	60	4	$24.0K
14	TORRENT PHARMACEUTICALS LTD	$1.4M	41	5	$34.6K
10	ABBOTT HEALTH CARE PRIVATE LIMITED	$500.0K	10	2	$50.0K

Inventia Healthcare Limited ranks #12 among 168 Indian Fenofibrate exporters. Average shipment value of $24.0K compared to the market average of $286.5K. The closest competitors by value are ABBOTT HEALTHCARE PRIVATE LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Fenofibrate Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	361	12.9%
SAHAR AIR	281	10.1%
SAHAR AIR CARGO ACC (INBOM4)	229	8.2%
DELHI AIR CARGO ACC (INDEL4)	227	8.1%
JNPT/ NHAVA SHEVA SEA	203	7.3%
DELHI AIR	143	5.1%
HYDERABAD ICD	125	4.5%
JNPT	115	4.1%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Fenofibrate Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fenofibrate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 60 individual customs records matching Inventia Healthcare Limited exporting Fenofibrate, covering 39 formulations to 6 countries via 14 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 81+ countries, 368+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fenofibrate

Fenofibrate

Inventia Healthcare Limited — Fenofibrate Exporter Profile

Inventia Healthcare Limited — Fenofibrate Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Fenofibrate?

Who Are the Top Buyers of Fenofibrate from Inventia Healthcare Limited?

What Is India's Total Fenofibrate Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Fenofibrate Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Fenofibrate Exporters?

What Fenofibrate Formulations Does Inventia Healthcare Limited Export?

Regulatory Requirements: Exporting Fenofibrate to Key Markets

United States — FDA

How Does Inventia Healthcare Limited Compare to Nearest Fenofibrate Exporters?

Which Indian Ports Ship Fenofibrate Exports?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Fenofibrate Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fenofibrate Export Data from Inventia Healthcare Limited

Fenofibrate Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source